RepliCel Life Sciences Inc (OTCQB:REPCF)

0.4019
Delayed Data
As of 11:13am ET
 -0.0107 / -2.59%
Today’s Change
0.26
Today|||52-Week Range
0.82
+24.04%
Year-to-Date
SECTOR
Non-Energy Minerals
INDUSTRY
Precious Metals
MARKET CAP
$22.7M

Company Description

RepliCel Life Sciences, Inc. is engaged in the business of developing and patenting a new hair follicle cell replication technology. Its cellular replication and implantation technology is designed to grow new hair follicles in patients suffering from androgenetic alopecia. The procedure is also designed to rejuvenate damaged, miniaturized hair follicles in balding scalp skin. It was formerly known as Newcastle Resources Ltd. and changed its name to RepliCel Life Sciences, Inc. on June 22, 2011. The company was founded on April 24, 1967 and is headquartered in Vancouver, Canada.

Contact Information

RepliCel Life Sciences, Inc.
401 West Georgia Street
Vancouver British Columbia V6B 5A1
P:(604) 248-8730
Investor Relations:
(604) 248-8696

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

David M. HallPresident, Chief Executive Officer & Director
Thomas Albert KordybackChief Financial Officer
Darrell PanichVice President-Clinical Affairs
Kevin McElweeChief Scientific Officer
Rolf HoffmannDirector & Chief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account